Published 7 January 2026 · 7 minutes reading time
Both contain semaglutide, but only one is approved for weight treatment. Learn the differences and why Wegovy is prescribed for weight loss.
Wegovy and Ozempic both contain semaglutide, but Wegovy is approved for obesity with a higher maximum dose. Ozempic is approved for type 2 diabetes and should be reserved for that indication.
Licensed Physician
Medicinskt granskad: 7 January 2026
Wegovy and Ozempic share the same active ingredient, but they are approved for different indications and doses.
Ozempic is approved for type 2 diabetes up to 2 mg weekly. Wegovy is approved for obesity with a higher dose up to 2.4 mg.
Wegovy is the medically appropriate option for obesity, and it avoids off-label Ozempic use that can affect diabetes supply.
Our physicians help you develop a safe and evidence-based plan for medical weight treatment.
Part of Curevo Health
Viktenheten is part of Curevo Health, Sweden’s digital specialist care platform.
